Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,126 | -19,142 | -9,439 | -57,775 | -46,731 |
| Depreciation Amortization | -387 | -309 | -182 | -1,481 | -1,195 |
| Accounts payable and accrued liabilities | -9 | -159 | 122 | -698 | -393 |
| Other Working Capital | -4,685 | -3,500 | -3,050 | -258 | 667 |
| Other Operating Activity | -16,927 | 4,526 | 2,344 | 10,930 | 8,232 |
| Operating Cash Flow | $-25,134 | $-18,584 | $-10,205 | $-49,282 | $-39,420 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -12,122 | -11,384 | -6,919 | -50,933 | -33,609 |
| Sale Of Investment | 35,465 | 25,500 | 18,000 | 84,425 | 68,674 |
| Other Investing Activity | 20,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $43,343 | $14,116 | $11,081 | $33,492 | $35,065 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10 | 10 | N/A | 5,467 | 5,449 |
| Other Financing Activity | 0 | 0 | 0 | -268 | -268 |
| Financing Cash Flow | $10 | $10 | $0 | $5,199 | $5,181 |
| Beginning Cash Position | 13,903 | 13,903 | 13,903 | 24,494 | 24,494 |
| End Cash Position | 32,122 | 9,445 | 14,779 | 13,903 | 25,320 |
| Net Cash Flow | $18,219 | $-4,458 | $876 | $-10,591 | $826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,134 | -18,584 | -10,205 | -49,282 | -39,420 |
| Free Cash Flow | -25,134 | -18,584 | -10,205 | -49,282 | -39,420 |